GlassScriptPhysician profile
Tomar Reisler
NPI 1326203852
$7,204.84
in general payments reported to CMS, 2019-2025
23 companies · $4,115 in 2025
The $4,115 reported for 2025 was more than what 89% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,255 · 2020: $114 · 2022: $75.00 · 2023: $888 · 2024: $758 · 2025: $4,115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,475 · Travel and Lodging: $1,338 · Long Term Medical Supply Or Device Loan: $873 · Consulting Fee: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,474.74 |
| Travel and Lodging | $1,338.16 |
| Long Term Medical Supply Or Device Loan | $872.75 |
| Consulting Fee | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $1,904.46 | 2024-2025 | |
| Abbvie INC. | $1,030.93 | 2023-2025 | |
| Integra Lifesciences Corporation | $917.55 | 2025 | Cytal, Integra, Integra Dermal Regeneration Template |
| Stryker Corporation | $679.07 | 2019 | |
| Merz North America, INC. | $539.97 | 2023-2025 | |
| Mentor Worldwide LLC | $468.97 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Smith+Nephew, INC. | $334.57 | 2019-2025 | Renasys Touch, Pico 14, Renasys Go V2 Home |
| Tela Bio, INC. | $216.82 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kerecis Limited | $213.71 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Kci USA, INC. | $163.73 | 2019-2020 | |
| Medtronic, INC. | $150.00 | 2022-2023 | Lapro-Clip, Merocel |
| Polarityte, INC. | $126.31 | 2019 | |
| Urgo Medical North America, LLC | $100.47 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Revance Therapeutics, INC. | $76.04 | 2025 | Daxxify |
| Motiva USA, LLC | $65.00 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $38.94 | 2025 | Restrata Wound Matrix |
| Solventum Corporation | $36.34 | 2025 | Prevena, V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice |
| Pacira Pharmaceuticals Incorporated | $36.01 | 2025 | Exparel |
| Osiris Therapeutics INC. | $31.88 | 2019 | |
| Galderma Laboratories, L.P. | $27.23 | 2023 | Dysport |
| Merck Sharp & Dohme LLC | $17.87 | 2025 | Lynparza, Keytruda |
| Depuy Synthes Sales INC. | $17.11 | 2020 | |
| Medtronic USA, INC. | $11.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tomar Reisler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.